The Alteplase Controversy Goes Prime Time

Just a few months ago, alteplase for acute ischemic stroke was assaulted in the pages of the BMJ. Academic debate on this subject is hardly novel, as the controversy within the ivory tower has dragged on almost since thrombolytics for stroke received therapeutic approval. However, as the use of alteplase grows, the number of patients […]

Read More…